New York State Teachers Retirement System Raises Stake in Prestige Consumer Healthcare Inc. $PBH

New York State Teachers Retirement System boosted its position in Prestige Consumer Healthcare Inc. (NYSE:PBH) by 1.3% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 58,135 shares of the company’s stock after buying an additional 745 shares during the quarter. New York State Teachers Retirement System owned approximately 0.12% of Prestige Consumer Healthcare worth $4,642,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds and other institutional investors have also bought and sold shares of the company. Envestnet Portfolio Solutions Inc. boosted its stake in Prestige Consumer Healthcare by 45.1% in the second quarter. Envestnet Portfolio Solutions Inc. now owns 4,311 shares of the company’s stock worth $344,000 after buying an additional 1,339 shares in the last quarter. Concurrent Investment Advisors LLC boosted its stake in Prestige Consumer Healthcare by 7.1% in the second quarter. Concurrent Investment Advisors LLC now owns 4,503 shares of the company’s stock worth $360,000 after buying an additional 300 shares in the last quarter. Inspire Investing LLC boosted its stake in Prestige Consumer Healthcare by 22.2% in the second quarter. Inspire Investing LLC now owns 4,890 shares of the company’s stock worth $390,000 after buying an additional 888 shares in the last quarter. Callan Family Office LLC purchased a new stake in Prestige Consumer Healthcare in the second quarter worth approximately $566,000. Finally, Blair William & Co. IL boosted its stake in Prestige Consumer Healthcare by 7.4% in the second quarter. Blair William & Co. IL now owns 113,941 shares of the company’s stock worth $9,098,000 after buying an additional 7,827 shares in the last quarter. Hedge funds and other institutional investors own 99.95% of the company’s stock.

Prestige Consumer Healthcare Price Performance

Shares of Prestige Consumer Healthcare stock opened at $62.22 on Tuesday. The company has a quick ratio of 2.99, a current ratio of 4.38 and a debt-to-equity ratio of 0.55. The company has a market cap of $3.06 billion, a PE ratio of 14.60, a P/E/G ratio of 1.96 and a beta of 0.44. The business has a 50 day moving average of $64.28 and a 200 day moving average of $75.10. Prestige Consumer Healthcare Inc. has a 52 week low of $60.15 and a 52 week high of $90.04.

Prestige Consumer Healthcare (NYSE:PBH) last announced its earnings results on Thursday, August 7th. The company reported $0.95 EPS for the quarter, missing analysts’ consensus estimates of $1.01 by ($0.06). The business had revenue of $249.53 million for the quarter, compared to the consensus estimate of $260.71 million. Prestige Consumer Healthcare had a net margin of 19.02% and a return on equity of 12.69%. Prestige Consumer Healthcare’s revenue was down 6.6% compared to the same quarter last year. During the same quarter in the prior year, the company earned $0.90 EPS. Prestige Consumer Healthcare has set its FY 2026 guidance at 4.500-4.580 EPS. As a group, equities research analysts forecast that Prestige Consumer Healthcare Inc. will post 4.5 earnings per share for the current year.

Analyst Ratings Changes

A number of research firms have recently weighed in on PBH. Weiss Ratings reissued a “hold (c)” rating on shares of Prestige Consumer Healthcare in a research note on Wednesday, October 8th. Zacks Research lowered Prestige Consumer Healthcare from a “hold” rating to a “strong sell” rating in a research note on Thursday, September 4th. Wall Street Zen lowered Prestige Consumer Healthcare from a “buy” rating to a “hold” rating in a research note on Saturday, August 9th. Canaccord Genuity Group dropped their price objective on Prestige Consumer Healthcare from $105.00 to $100.00 and set a “buy” rating for the company in a research note on Friday, August 8th. Finally, Sidoti raised Prestige Consumer Healthcare from a “neutral” rating to a “buy” rating and set a $80.00 price objective for the company in a research note on Wednesday, September 24th. Four research analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Hold” and an average target price of $94.80.

Prestige Consumer Healthcare Profile

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.